ANN ARBOR, Mich. (AP) — ANN ARBOR, Mich. (AP) — Esperion Therapeutics Inc. (ESPR) on Monday reported a loss of $61.9 million in its second quarter.

The Ann Arbor, Michigan-based company said it had a loss of 33 cents per share. Losses, adjusted to extinguish debt, came to 5 cents per share.

The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 15 cents per share.

The biopharmaceutical company posted revenue of $73.8 million in the period, also exceeding Street forecasts. Five analysts surveyed by Zacks expected $51.9 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ESPR at https://www.zacks.com/ap/ESPR